Clarifying Assumptions and Outcomes in Cost-effectiveness Analyses

被引：0
|
作者：
ten Haaf, Kevin [1 ]
de Koning, Harry J. [1 ]
机构：
[1] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands
来源：
JAMA ONCOLOGY | 2016年 / 2卷 / 02期
关键词：
D O I：
10.1001/jamaoncol.2015.4457
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：277 / 278
页数：3
相关论文
共 50 条
  • [1] Clarifying Assumptions and Outcomes in Cost-effectiveness Analyses Reply
    Goffin, John R.
    Flanagan, William M.
    Evans, William K.
    JAMA ONCOLOGY, 2016, 2 (02) : 278 - 279
  • [2] Clarifying the role of values in cost-effectiveness
    Gusmano, Michael K.
    Kaebnick, Gregory
    HEALTH ECONOMICS POLICY AND LAW, 2016, 11 (04) : 439 - 443
  • [3] COST-EFFECTIVENESS ANALYSES
    STEINBERG, EP
    NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (02): : 123 - 123
  • [4] IMPACT OF STRUCTURAL ASSUMPTIONS ON COST-EFFECTIVENESS OUTCOMES: TOWARDS A STANDARDIZED COST-EFFECTIVENESS MODEL FOR ADJUVANT BREAST CANCER THERAPIES
    Frederix, G. W.
    Van Hasselt, J. G.
    Schellens, J. H.
    Hovels, A. M.
    Huitema, A. D.
    Raaijmakers, J. A.
    Severens, J.
    VALUE IN HEALTH, 2012, 15 (07) : A282 - A283
  • [5] The "e" In Cost-Effectiveness Analyses: Efficacy Or Effectiveness Of Asthma Medications Used In Cost-Effectiveness Analyses?
    Dilokthornsakul, P.
    Chaiyakunapruk, N.
    Campbell, J. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [6] Significant Heterogeneity in Parameter Assumptions in Cost-Effectiveness Analyses in Prostate Adenocarcinoma: A Systematic Review
    Butala, A. A.
    Bryant, C. M.
    Nichols, R. C., Jr.
    Henderson, R. H.
    Hoppe, B. S.
    Mendenhall, N. P.
    Vapiwala, N.
    Vega, R. Mailhot
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S181 - S182
  • [7] Heterogeneity in Radiotherapeutic Parameter Assumptions in Cost-Effectiveness Analyses in Prostate Cancer: A Call for Uniformity
    Butala, Anish A.
    Huang, Christina C.
    Bryant, Curtis M.
    Henderson, Randal H.
    Hoppe, Bradford S.
    Mendenhall, Nancy P.
    Vapiwala, Neha
    Vega, Raymond B. Mailhot
    VALUE IN HEALTH, 2022, 25 (02) : 171 - 177
  • [8] Industry involvement and baseline assumptions of cost-effectiveness analyses: diagnostic accuracy of the Papanicolaou test
    Polyzos, Nikolaos P.
    Valachis, Antonis
    Mauri, Davide
    Ioannidis, John P. A.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2011, 183 (06) : E337 - E343
  • [9] OPTIMAL COST-EFFECTIVENESS ANALYSES
    NIGHTINGALE, SD
    JOURNAL OF GENERAL INTERNAL MEDICINE, 1992, 7 (03) : 369 - 370
  • [10] Interpretation of cost-effectiveness analyses
    Douglas K. Owens
    Journal of General Internal Medicine, 1998, 13 : 716 - 717
12345